FDA News

Latest News

UCB Anticipates Delay to FDA Bimekizumab Decision
UCB Anticipates Delay to FDA Bimekizumab Decision

September 19th 2023

The company shared anticipation that their BLA decision for bimekizumab to treat adults with plaque psoriasis will not come before the end of this month.

Default thumbnail for Diabetes Dialogue podcast. Features headshots of hosts and podcast logo.
Diabetes Dialogue: Accu-Chek Solo and Abbott Acquiring Bigfoot Biomedical

September 19th 2023

Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Expert Perspective: FDA CRDAC Vote on Patisiran for ATTR-CM, with Ahmad Masri, MD, MS

September 16th 2023

Credit: US Food and Drug Administration
FDA Committee Endorses Patisiran for ATTR Cardiomyopathy

September 14th 2023

Arcutis Announces Supplemental New Drug Application of Roflumilast for Atopic Dermatitis in Adults, Children
Arcutis Announces Supplemental New Drug Application of Roflumilast for Atopic Dermatitis in Adults, Children

September 12th 2023

Video Interviews
Podcasts
Thumbnail featuring podcast hosts and logo for Diabetes Dialogue

More News

© 2023 MJH Life Sciences

All rights reserved.